Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Spectinomycin
Drug ID BADD_D02063
Description An antibiotic produced by Streptomyces spectabilis. It is active against gram-negative bacteria and used for the treatment of gonorrhea.
Indications and Usage For use in the treatment of acute gonorrheal urethritis and proctitis in the male and acute gonorrheal cervicitis and proctitis in the female when due to susceptible strains of Neisseria gonorrhoeae.
Marketing Status Discontinued
ATC Code J01XX04
DrugBank ID DB00919
KEGG ID D08526
MeSH ID D000198
PubChem ID 15541
TTD Drug ID D02PCR
NDC Product Code 0009-5038
Synonyms Spectinomycin | Actinospectacin | Prospec | Ferkel Spectam | Spectam, Ferkel | Kempi | Spectinomycin Dihydrochloride, Pentahydrate | Spectam | Spectinomycin Dihydrochloride, Anhydrous | Trobicin | Salmosan-T | Salmosan T | Stanilo | Spectinomycin Hydrochloride | Adspec
Chemical Information
Molecular Formula C14H24N2O7
CAS Registry Number 1695-77-8
SMILES CC1CC(=O)C2(C(O1)OC3C(C(C(C(C3O2)NC)O)NC)O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Anaphylactoid reaction24.06.03.007; 10.01.07.003--Not Available
Body temperature increased13.15.01.001--Not Available
Chills15.05.03.016; 08.01.09.001--
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Hypersensitivity10.01.03.003--
Insomnia19.02.01.002; 17.15.03.002--
Nausea07.01.07.001--
Nephropathy toxic12.03.01.010; 20.05.03.002--Not Available
Tenderness08.01.08.005--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Urine output13.13.03.003--Not Available
The 1th Page    1    Total 1 Pages